Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.43 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.43 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.43 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.43 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.41 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.41 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | PTPRF | P10586 | 3/20 | 0.39 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25626922 | 1.00 | PIM1 (0.43) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL25019644 | 1.00 | PIM1 (0.43) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL25645836 | 1.00 | PIM1 (0.43) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL22329964 | 1.00 | PIM1 (0.43) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL24215883 | 0.99 | PIM1 (0.44) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL17425603 | 0.99 | PIM1 (0.44) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL26080405 | 0.97 | ALOX5 (0.47) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL25645959 | 0.97 | ALOX5 (0.47) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL24525895 | 0.97 | ALOX5 (0.46) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL24526090 | 0.97 | ALOX5 (0.46) | PIM1CSNK2A2CSNK2BPIM3PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| WO-2022025714-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2022-02-03 | — | — | WO | disclosed |
| WO-2022015084-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2022-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CYP1A2, CYP1A1 | PIM1 3702/4885CSNK2A2 963/4885CSNK2B 1056/4885 |
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CRY2, CYP1A1 | PIM1 2458/4885CSNK2A2 569/4885CSNK2B 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.